CION Ameerpet
Kidney Cancer · Kidney Function & Living With One Kidney
Cancer in both kidneys — what it means for your kidney function
Finding a tumour in each kidney sounds like the worst possible news, and it usually is not what it first appears to be. Kidney cancer found on both sides at once most often means two separate cancers that started independently — not one cancer that has travelled across from the other side. What it does change is how carefully the plan has to be built, because with both kidneys involved there is no healthy spare side, and every decision is now weighed against how much working kidney tissue you will be left with.
- Usually two separate cancers — Bilateral disease most often means independent primary tumours, each staged on its own. It does not automatically mean the cancer is advanced.
- Kidney function becomes part of the cancer plan — With no unaffected side to fall back on, how much filtering tissue each kidney keeps is weighed alongside clearing the tumour.
- Kidney-sparing first, one side at a time — Where tumour size and position allow, tissue is spared on each side, and the two sides are usually treated in sequence rather than together.
- Medical oncology led in-house — Imaging review, kidney-function bloods, genetic counselling, immunotherapy and targeted therapy are delivered by our own CION team.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
First, the distinction that matters
What cancer in both kidneys usually means — and what it does to kidney function
Cancer in both kidneys is not, in most cases, one cancer that has spread from one side to the other. Far more often it is two separate primary tumours that arose independently in the same person. That matters enormously, because separate primaries are assessed and staged on their own merits, whereas a cancer that has genuinely travelled is a different situation with a different plan. Our kidney cancer guide covers the condition as a whole; this page stays with one question — what involvement of both kidneys means for the function you are left with.
Which of those two pictures you are in is a question for the imaging. How the lesions look, where they sit, whether they behave the same way on contrast, and sometimes what the pathology shows, are what separate two independent cancers from one that has spread. It is also worth remembering that not everything seen on a scan of the second kidney turns out to be cancer at all: cysts and benign tumours are common findings, and a lesion on the other side still has to earn its diagnosis. How that distinction is drawn is set out in detail on our page about bilateral and multifocal kidney tumours.
Why kidney function stops being a background concern. When one kidney is affected and the other is healthy, the healthy side is a safety net: it can take over the work if the affected kidney has to be removed. When both sides carry tumours, that safety net is gone, and the arithmetic changes. Removing both kidneys would mean dialysis, so no plan starts there. Instead, the aim becomes clearing the cancer while keeping as much filtering tissue as possible on each side — which is why kidney-sparing surgery moves from being the preferred option to being close to essential. What that operation involves, and when a kidney can and cannot be spared, is explained on our partial nephrectomy page.
Bilateral disease also raises the inherited question. Tumours on both sides, several tumours at once, or a diagnosis at a younger age are recognised reasons to look at whether an inherited condition is involved. Some inherited conditions are associated with kidney tumours appearing on both sides and recurring over a lifetime, and that possibility changes the plan in a very practical way: if more tumours are likely in future, every gram of kidney tissue saved now matters later. The route to that answer is genetic counselling before any test, so that you understand what a result would and would not tell you, and what it might mean for your relatives. That counselling is delivered in-house at CION.
What CION delivers, and what is coordinated. Diagnosis and monitoring — CT, MRI and ultrasound review, kidney biopsy, creatinine and eGFR, urine protein — along with genetic counselling, immunotherapy, targeted and mTOR therapy, radiation and long-term surveillance, are delivered in-house by our own medical oncology team. All kidney surgery, whether kidney-sparing or complete removal, and ablation and PET-CT, are coordinated with specialist urology, uro-oncology and interventional radiology partners and may be billed at the partner centre. You are told which is which, and what each will cost, before anything is booked.
Five things genuinely decide how much kidney function you keep. Your oncologist should be able to talk through each of them using your own scans and bloods:
- The size and number of tumours on each side. Small, few and separate is a very different proposition from large or numerous, and the two sides are often not equally affected.
- Where each tumour sits within its kidney. A tumour bulging from the surface can usually be removed with a rim of normal tissue; one buried centrally, close to the collecting system or the main vessels, costs far more tissue to reach.
- How well your kidneys were filtering to begin with. A normal starting eGFR gives the team room to work with. Reduced function, diabetes or long-standing high blood pressure narrows the margin and pushes harder towards sparing tissue.
- Whether an inherited condition is likely. If further tumours are expected over the years, the plan is written for a lifetime of kidney-sparing rather than for one operation.
- Whether the disease has gone beyond the kidneys. If it has, systemic treatment usually leads and local treatment is planned around it, rather than the other way round.
If you have two reports and nobody has yet read them together, that is the first thing to fix — a plan for both kidneys cannot be made one scan at a time. Book a free consultation and have both sides reviewed in one sitting.
Did you know?
A tumour in each kidney does not automatically mean stage 4 disease. When the two tumours are separate primary cancers, each one is staged on its own findings, so it is entirely possible to have early-stage cancer on both sides. Stage 4 describes cancer that has spread beyond the kidney, which is a different finding altogether. If your reports have left you assuming the worst, ask your team directly which of the two pictures your scans actually describe.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Both kidneys deserve one plan, not two opinions
Every case at CION goes to a tumour board, where urology, medical oncology and radiology look at both sides together. Free first consultation, and no commitment to start treatment.
How each side is judged
What decides the approach for each kidney
Each kidney is assessed on its own findings, then the two assessments are reconciled into a single plan. NCCN guidance builds preservation of kidney function into how kidney cancer surgery is chosen, which is why several of these factors are weighed before anything is booked rather than afterwards.
| Factor | Why it matters when both kidneys are involved | How it is handled |
|---|---|---|
| Size and number of tumours on each side | The two sides are rarely equally affected. A small tumour on one side and a larger one on the other usually sets the order in which they are dealt with. | Established on dedicated multiphase imaging of both kidneys, reviewed in-house and taken to the tumour board as one picture rather than two reports. |
| Position within the kidney | A tumour bulging from the surface can often be removed with a rim of normal tissue. One sitting centrally, near the collecting system or the main vessels, costs far more working tissue to reach safely. | Judged on the same imaging by the surgical team. It is the single biggest determinant of whether kidney-sparing surgery is technically possible on that side. |
| Kidney function before treatment | Your starting eGFR sets the margin the team has to work within. The less function you begin with, the harder every decision leans towards sparing tissue rather than removing a kidney. | Creatinine, eGFR and urine protein are measured in-house before treatment and repeated between stages, so each decision is made against a current number. |
| Whether an inherited condition is likely | If further tumours are expected across a lifetime, the plan has to survive more than one operation. Preserving tissue now is what makes treating a future tumour possible. | Genetic counselling before any testing, delivered in-house. Where a syndrome is confirmed, surveillance is longer and closer, and thresholds for operating are usually reconsidered. |
| Whether disease has gone beyond the kidneys | If the cancer has spread, systemic treatment usually leads and any local treatment is planned around it. Bilateral tumours alone do not put you in this group. | Assessed on chest and abdominal imaging. Systemic treatment, when it is needed, is led in-house by CION medical oncology; PET-CT, where indicated, is coordinated with a partner centre. |
| The order and spacing of the two sides | Treating both kidneys in one sitting removes filtering capacity from both sides at once and leaves nothing in reserve during recovery. | Usually staged: the more pressing side first, recovery, a kidney-function recheck, then the second side planned against that new baseline. All surgery is coordinated with specialist urology and uro-oncology partners. |
None of these is decided by a rule you can apply to yourself from a report. They are decided together, on your images, by people who can see both kidneys at once.
Step by step
How a plan for both kidneys is actually built
This is the sequence a bilateral kidney cancer usually follows at CION. It is deliberately unhurried at the start, because the decisions taken in the first fortnight are what determine how much kidney you keep for the rest of your life.
Image both kidneys properly, and the chest
Dedicated multiphase CT, or MRI where contrast is a problem, covering both kidneys in the same study, plus imaging of the chest. A scan done for something else, or one that covered only the side that caused symptoms, is not enough to plan two kidneys on.
Establish a kidney-function baseline before anything is removed
Creatinine, eGFR and urine protein, measured in-house before treatment starts. Without that number there is nothing to judge the effect of the first operation against, and no honest way to plan the second side. Blood pressure and blood sugar are reviewed at the same time.
Decide which lesions are genuinely cancer, and whether they are separate
Radiology, and biopsy where the answer would change what is done, settle whether both sides carry cancer and whether they are independent primaries. Some lesions turn out to be cysts or benign tumours and are simply followed, which spares an operation nobody needed.
Take both sides to the tumour board together
Urology, medical oncology and radiology look at the two kidneys as one problem and agree what is treated, in what order, and what is watched. This is where kidney-sparing is argued for on each side, and where staging the operations rather than combining them is usually decided.
Formalise the genetic question — counselling before testing
Bilateral tumours, several tumours, a young diagnosis or a family history all justify asking whether an inherited condition is involved. Counselling comes first so that you decide with the implications in front of you. This is delivered in-house, and the answer often changes how much tissue the team fights to keep.
Treat one side, recheck function, then plan the other
Kidney-sparing surgery wherever the tumour allows, coordinated with specialist urology and uro-oncology partners. Where an operation would cost more function than the tumour currently threatens, ablation, precisely targeted radiation or scheduled active surveillance may be the better answer for that side. Function is remeasured before the second side is planned.
Surveillance that watches the cancer and the function together
After treatment, imaging of both kidneys and kidney-function bloods run on the same schedule, at intervals set by your results rather than a fixed rule. Where an inherited cause is confirmed, that surveillance is longer and closer, because new tumours can appear years later.
If the disease has spread beyond the kidneys. Systemic treatment then leads, and it is delivered in-house by our own team: immunotherapy built on immune checkpoint inhibition, combination immunotherapy, VEGF-directed targeted therapy or an mTOR inhibitor, chosen on the subtype and risk profile rather than on the number of kidneys involved, with kidney function reviewed before and during treatment. Which class suits which situation, and what the sequence looks like, is set out on our kidney cancer treatment in Hyderabad page.
Take the first step
Ask what your scans actually show, before anything is booked
A written second opinion costs you nothing and takes one appointment. If your plan is already the right one, we will tell you that plainly.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Cancer in both kidneys — your questions answered
Does cancer in both kidneys mean the cancer has spread?
Usually not. When kidney cancer is found in both kidneys at the same time, it most often means two separate primary tumours have arisen independently, rather than one cancer that has travelled from one side to the other. That distinction matters, because separate primaries are staged on their own merits, so a tumour in each kidney does not automatically make the disease advanced. Radiology, and where necessary pathology, is what settles the question, and imaging of the chest and abdomen is done to check whether anything has spread beyond the kidneys. Ask your team plainly which of the two pictures your scans describe, because almost everything that follows depends on the answer.
Will I need dialysis if there is cancer in both kidneys?
For most people, no. Dialysis becomes necessary only when there is too little working kidney tissue left to clear waste and fluid, and the whole point of planning bilateral kidney cancer carefully is to avoid arriving there. Kidney-sparing surgery is preferred on each side wherever the size and position of the tumour allow it, a small tumour on the second side is sometimes watched rather than treated straight away, and the two sides are usually dealt with one at a time so that function can recover and be measured in between. Your own risk depends on your kidney-function results and on how much tissue each side can keep, not on the word bilateral.
Can both kidneys be operated on at the same time?
Sometimes, but more often the sides are dealt with one at a time. Operating on both kidneys in a single sitting takes filtering capacity from both sides at once and leaves nothing in reserve while the body recovers, so the more urgent or larger tumour is often treated first, function is rechecked once recovery is under way, and the second side is then planned against that new baseline. Which side goes first, and how long is left in between, is a surgical judgement made on your imaging and your kidney-function results. All kidney surgery for CION patients is coordinated with specialist urology and uro-oncology partners and may be billed at the partner centre.
Is cancer in both kidneys hereditary?
Not always, but tumours in both kidneys are one of the recognised reasons to take the question seriously, particularly alongside a younger age at diagnosis, several tumours at once, or close relatives who have had kidney tumours. Some inherited conditions are associated with kidney tumours appearing on both sides and returning over a lifetime, and knowing whether one of them is in play changes how hard the team works to spare tissue and how long surveillance continues. The proper route is genetic counselling before any test, so you understand what a result would and would not tell you, and what it might mean for your family. That counselling is delivered in-house at CION.
What if a tumour on the second kidney cannot be removed safely?
There are options short of removing that kidney. A small tumour that is not growing may be kept under active surveillance, which is a scheduled plan with repeat imaging rather than doing nothing. A tumour sitting where surgery would cost more working tissue than the tumour is currently threatening may be treated with ablation instead, and precisely targeted radiation is another route where an operation is not suitable. Ablation and PET-CT are coordinated with specialist interventional radiology and partner centres, while radiation, surveillance imaging review and kidney-function monitoring are delivered in-house by our own team. Which option fits is decided at a tumour board, on your imaging, not on preference.
How is treatment for bilateral RCC different from a tumour in one kidney?
The cancer principles are the same, but every decision is weighed twice, because there is no healthy spare side to fall back on. Kidney-sparing surgery moves from preferable to close to essential, the order and timing of treating each side become part of the plan rather than an afterthought, and kidney function is measured before, between and after treatment instead of only at the end. If disease has spread beyond the kidneys, the systemic treatment classes are the same as in one-sided disease, chosen on subtype and risk profile, with kidney function reviewed before and during. Surveillance afterwards is usually longer and closer, especially where an inherited cause is confirmed.
This page is general health information about kidney cancer involving both kidneys. It is not a diagnosis and it cannot replace a review of your own scans and blood results by a doctor who has seen them. Only a clinician with your imaging, your pathology and your kidney-function trend can say what your situation means or what should be done about it. If you have been told there is a tumour in each kidney, please arrange a specialist review rather than waiting — and contact your team promptly if you notice visible blood in the urine, a marked fall in how much urine you pass, new swelling of the legs or face, or breathlessness.